Carlyle High Yield Partners 2008-1 Ltd. Ratings Withdrawn Following Optional Redemption Jul 11

  • ID: 1930918
  • July 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) July 7, 2011--Standard & Poor's Ratings Services today withdrew its ratings on the class B, C, and D notes from Carlyle High Yield Partners 2008-1 Ltd., a collateralized loan obligation (CLO) transaction managed by Carlyle Investment Management LLC (see list). Today's withdrawals follow the optional redemption of the rated notes, pursuant to section 9.2(a)(ii) of the indenture, on the May 25, 2011, distribution date. RELATED CRITERIA AND RESEARCH Update To Global Methodologies And Assumptions For Corporate Cash Flow And Synthetic CDOs, published Sept. 17, 2009. General Criteria: Understanding Standard & Poor?s Rating Definitions, published June 3, 2009. Update To General Cash Flow Analytics Criteria For CDO Securitizations, published Oct. 17, 2006. CDO Spotlight: General Cash...

Companies mentioned in this report are: Carlyle High Yield Partners 2008-1 Ltd
Action: Withdrawn

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Carlyle High Yield Partners 2008-1 Ltd

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.